Raw plant-based diet linked to sperm reappearance in men with azoospermia

In a finding that has set social media alight and left andrologists cautiously intrigued, three men whose semen analyses had previously shown no sperm at all began producing measurable spermatozoa roughly ten weeks after starting an intensive lifestyle programme built around a predominantly raw, whole-food, plant-based diet. The observations, published as a case series in Frontiers in Urology, do not prove that the programme restored sperm production. But the consistent temporal pattern, in three men with some of the most severe diagnoses in male infertility, is exactly the kind of signal that researchers say justifies rigorous controlled trials.

Azoospermia, the complete absence of spermatozoa in the ejaculate, is among the most severe forms of male infertility. It affects roughly one per cent of all men and ten to fifteen per cent of men seeking fertility care, and it is broadly divided into obstructive azoospermia, where sperm production is preserved but transport is blocked, and non-obstructive azoospermia, where spermatogenesis itself is impaired. The distinction matters enormously for prognosis and treatment, because obstructive cases can often be managed with surgical sperm retrieval, while non-obstructive cases frequently resist both hormonal therapy and extraction procedures.

The programme the three participants undertook was strikingly prescriptive. During the intensive phase, each man consumed a predominantly raw, plant-based dietary pattern with minimum daily targets of 454 grams of leafy green and cruciferous vegetables, either half a cup of ground flaxseed or chia seeds or three tablespoons of cold-pressed flaxseed oil, and roughly three to 3.8 litres of water adjusted for body weight. Fruit was limited to about a quarter of total food volume, and animal-derived foods, refined sugars, ultra-processed foods and alcohol were excluded. Progressive physical activity, sleep optimisation, stress management and avoidance of tobacco smoke completed the protocol, with micronutrient supplementation guided by laboratory findings, including vitamin D3-K2 when 25-hydroxyvitamin D fell below the laboratory reference interval and routine vitamin B12 supplementation because animal foods were excluded.

Case 1, a 38-year-old man with three years of primary infertility, obesity, hypertension and obstructive sleep apnoea, had at least two prior semen analyses reporting azoospermia, including centrifuged specimens. He began the programme in April 2025, roughly eleven months after estimated cessation of fertility-directed pharmacotherapy. Ten weeks later, in July 2025, spermatozoa were detected at a concentration of 1.6 million per millilitre, and they remained detectable at 1.4 million per millilitre in March 2026. Over the same period his weight fell from 100.6 to 88.0 kilograms, his body mass index dropped from 34.8 to 30.5, and his testosterone rose from 1.22 to 11.9 nanograms per millilitre, with prolactin normalising from 24.5 to 8.8.

Case 2, a 40-year-old man with five years of infertility, had received clomiphene citrate, human chorionic gonadotropin, human menopausal gonadotropin and antioxidants before undergoing testicular sperm extraction in August 2023, which yielded no viable spermatozoa. He started the programme in January 2026, some twenty-nine months after that unsuccessful procedure. By March 2026, ten weeks in, his semen analysis showed sperm at 2.0 million per millilitre with fifteen per cent progressive motility. His weight declined from 89.7 to 81.7 kilograms across the documented interval. A later seminal culture isolated Staphylococcus aureus, a finding the authors describe as temporally separate and of uncertain relationship to the semen results.

Case 3, a 36-year-old man, had documented severe oligozoospermia at 0.1 million per millilitre in February 2023, followed by azoospermia in March 2023 despite repeat evaluation. He had received fertility-directed hormonal therapy, antioxidants and herbal preparations, and was contemplating surgical sperm retrieval when he elected to try the lifestyle programme first, beginning in March 2026. In May 2026, ten weeks later, spermatozoa were detected at 2.2 million per millilitre with thirty-five per cent progressive motility and twenty per cent normal morphology. His weight fell from 86.8 to 77.8 kilograms, and testosterone remained within the reference interval at 7.2 nanograms per millilitre.

All three concentrations remained within a severe oligozoospermic range, well below the World Health Organization lower reference limit of sixteen million per millilitre, and the trajectories were neither uniform nor linear. Case 1 reported resuming episodic binge alcohol consumption after the intensive phase, coinciding with variation in his subsequent semen findings, though the authors stress this temporal association does not establish causality. Participants also reported improvements in body weight, sleep quality, physical-activity tolerance, libido, perceived energy and general well-being, with no major adverse events documented during follow-up.

From a mechanistic standpoint, the authors argue that weight loss is a plausible co-intervention rather than a background variable. Obesity and related metabolic dysfunction can impair spermatogenesis through endocrine dysregulation, systemic inflammation, oxidative stress and testicular metabolic or lipotoxic pathways. Diet-induced weight loss has been associated with increased sperm concentration and total sperm count in men with obesity in randomised trial data, though that evidence does not demonstrate restoration of spermatogenesis in azoospermia. Using the conventional approximation of 7,700 kilocalories per kilogram of weight loss, the authors estimated mean energy deficits of roughly 225 kilocalories per day for Case 1, 61 for Case 2 and 59 for Case 3, though they caution these are retrospective approximations, not direct measurements, and that most of each measurement interval preceded programme initiation.

The limitations are substantial and the authors are unusually candid about them. The series was uncontrolled, aetiological assessment was incomplete, and obstruction could not be excluded because testicular examination, assessment of testicular volume and reproductive-tract imaging were not documented consistently. Karyotyping and Y-chromosome microdeletion testing were unavailable, so genetic causes could not be evaluated. Adherence was self-reported, with no validated adherence scale, weighed food record, repeated 24-hour dietary recall or objective dietary biomarker. WHO-concordant confirmation of every pre-intervention azoospermic specimen could not be independently verified, and semen-analysis methods differed across external laboratories, introducing potential inter-laboratory and operator variability.

Previous fertility-directed treatment remains an important alternative explanation. Treatment-to-programme intervals were approximately eleven, twenty-nine and thirty-three months for the three cases, with spermatozoa first detected fourteen, thirty-one and thirty-five months after the corresponding reference events. These long intervals make a direct short-term carryover effect less plausible, but delayed or interacting treatment effects, and earlier unobserved reappearance of spermatozoa, cannot be excluded because exact cessation dates and continuous semen surveillance were unavailable. The authors conclude that these observations identify a clinically relevant and understudied question, whether modification of metabolic and lifestyle factors can influence spermatogenic function in selected men with azoospermia, and they call for prospective controlled studies incorporating WHO-standardised semen assessment, comprehensive andrologic evaluation, objective adherence measures and clinically meaningful reproductive outcomes such as conception and live birth.

Subject of Research: Case Report: Reappearance of spermatozoa following multicomponent lifestyle modification in men with previously diagnosed azoospermia: a case series

Article Title: Case Report: Reappearance of spermatozoa following multicomponent lifestyle modification in men with previously diagnosed azoospermia: a case series

Article References: Enwere, M., El-Hussein, M. T., Davies, E., & Holmes, L., Jr. (2026). Case Report: Reappearance of spermatozoa following multicomponent lifestyle modification in men with previously diagnosed azoospermia: a case series. Frontiers in Urology, 6, Article 1903697. https://doi.org/10.3389/fruro.2026.1903697

Image Credits: AI Generated

DOI: 10.3389/fruro.2026.1903697

Keywords: Case, Report, Reappearance, spermatozoa, following, multicomponent, lifestyle, modification, previously, diagnosed, azoospermia, series